U.S. Pharmaceuticals - NDC products
NDC labeler, manufacturer of drugs and pharmaceuticals
Products with assigned NDCs are displayed. Select the NDC to see product information. Select the Trade Name to see similar products.
NDC | Trade Name | Labeler Name | Deleted | Deleted Date |
---|---|---|---|---|
63539-0193 | BOSULIF | U.S. Pharmaceuticals | NO | |
63539-0117 | BOSULIF | U.S. Pharmaceuticals | NO | |
63539-0221 | Caverject Impulse | U.S. Pharmaceuticals | NO | |
63539-0121 | Caverject Impulse | U.S. Pharmaceuticals | NO | |
63539-0473 | CHANTIX | U.S. Pharmaceuticals | YES | No later than 2023-12-19 |
63539-0236 | CIBINQO | U.S. Pharmaceuticals | NO | |
63539-0336 | CIBINQO | U.S. Pharmaceuticals | NO | |
63539-0436 | CIBINQO | U.S. Pharmaceuticals | NO | |
63539-0011 | Cleocin | U.S. Pharmaceuticals | YES | No later than 2020-12-31 |
63539-0112 | Duavee | U.S. Pharmaceuticals | YES | No later than 2019-12-28 |
63539-0122 | Duavee | U.S. Pharmaceuticals | NO | |
63539-0252 | Elrexfio | U.S. Pharmaceuticals | NO | |
63539-0021 | Estring | U.S. Pharmaceuticals | YES | No later than 2023-12-19 |
63539-0284 | Ibrance | U.S. Pharmaceuticals | NO | |
63539-0486 | Ibrance | U.S. Pharmaceuticals | NO | |
63539-0688 | Ibrance | U.S. Pharmaceuticals | NO | |
63539-0189 | Ibrance | U.S. Pharmaceuticals | NO | |
63539-0188 | Ibrance | U.S. Pharmaceuticals | NO | |
63539-0187 | Ibrance | U.S. Pharmaceuticals | NO | |
63539-0026 | INLYTA | U.S. Pharmaceuticals | NO | |
63539-0044 | INLYTA | U.S. Pharmaceuticals | NO | |
63539-0334 | Litfulo | U.S. Pharmaceuticals | NO | |
63539-0927 | Lorbrena | U.S. Pharmaceuticals | NO | |
63539-0014 | Lyrica | U.S. Pharmaceuticals | YES | No later than 2022-12-30 |
63539-0013 | Lyrica | U.S. Pharmaceuticals | YES | No later than 2022-12-30 |
63539-0024 | Lyrica CR | U.S. Pharmaceuticals | YES | No later than 2022-12-30 |
63539-5195 | Nicotrol (Professional Sample) | U.S. Pharmaceuticals | YES | No later than 2019-03-26 |
63539-0039 | Nicotrol (Professional Sample) | US Pharmaceuticals | YES | No later than 2019-03-18 |
63539-0234 | Relpax | U.S. Pharmaceuticals | YES | No later than 2021-09-22 |
63539-0017 | SUTENT | U.S. Pharmaceuticals | NO | |
63539-0019 | SUTENT | U.S. Pharmaceuticals | NO | |
63539-0295 | Talzenna | U.S. Pharmaceuticals | YES | 2027-01-31 |
63539-0051 | Talzenna | U.S. Pharmaceuticals | YES | 2026-06-30 |
63539-0183 | Toviaz | U.S. Pharmaceuticals | NO | |
63539-0242 | Toviaz | U.S. Pharmaceuticals | NO | |
63539-0274 | Velsipity | U.S. Pharmaceuticals | NO | |
63539-0422 | Viagra | U.S. Pharmaceuticals | YES | No later than 2021-09-22 |
63539-0421 | Viagra | U.S. Pharmaceuticals | YES | No later than 2021-09-22 |
63539-0197 | Vizimpro | U.S. Pharmaceuticals | NO | |
63539-0016 | XELJANZ | U.S. Pharmaceuticals | NO | |
63539-0012 | XELJANZ | U.S. Pharmaceuticals | NO | |
63539-0501 | XELJANZ XR | U.S. Pharmaceuticals | NO | |
63539-0502 | XELJANZ XR | U.S. Pharmaceuticals | NO | |
63539-0135 | ZAVZPRET | U.S. Pharmaceuticals | NO |
Thank you for choosing Find-A-Code, please Sign In to remove ads.